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Abstract  
Background: Older adults have a 5 to 8-fold increased risk for all-cause mortality 
during the first 3 months after hip fracture, caused by low-energy trauma due to 
osteoporosis. POSSUM system is used in the assessment of outcomes in surgical 
patients. 
Objective: The aim of this study was to evaluate the performance POSSUM system 
(POSSUM, P-POSSUM and Orthopedic-POSSUM) on predicting 30-day morbimortality 
in elderly patients undergoing emergent hip fracture surgery. 
Design: Retrospective cohort study. 
Setting:  From 1st January 2014 to 31st December 2015, at a University Hospital.   
Patients: Elderly patients (≥65 years-old) admitted with hip fracture that underwent 
surgery. From 408 patients selected, 328 were excluded for not being submitted to 
emergency surgery. Data from the remaining 80 patients was retrospectively collected 
from the clinical files.  
Main outcome measures: POSSUM system’s performance and calibration for predicting 
morbimortality were assessed. Observed vs expected morbidity and mortality were 
compared using area under the Receiver Operating Characteristic (ROC-AUC) curves 
and Standardized Mortality Ratio (SMR) and the model goodness of fit was assessed 
using the Hosmer-Lemeshow test (H-LT). 
Results: The overall rate of 30 days mortality and morbidity was 6.3% and 38.8%, 
respectively. ROC curves of POSSUM system showed good discriminative ability for 
mortality (AUC=0.879; 95%CI 0.763-0.994) but poor for morbidity (AUC=0.647; 95%CI 
0.524-0.771). All models showed good calibration and goodness of fit (H-L T p-values 
for O-POSSUM/POSSUM and P-POSSUM were respectively 0.4627 and 0.2476 for 
mortality and 0.0932 for O-POSSUM morbidity). SMR indicated significantly fewer than 
expected deaths for O-POSSUM/POSSUM (0.525; 95%CI 0.065-0.985) but not for P-
POSSUM (1.321; 95%CI 0.163-2.479). 
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Conclusions: POSSUM system is better for predicting mortality than morbidity. All 
models showed good calibration and goodness of fit. However, SMRs showed mixed 
results. We showed that POSSUM can be used for predicting 30-day mortality in 
elderly patients undergoing emergent hip fracture surgery. 
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Background  
Hip fractures caused by low-energy trauma are one of the most serious consequences 
of osteoporosis. According to the World Health Organization (WHO), hip fractures 
frequently result in chronic pain, loss of mobility, decreased functional capacity and 
increased mortality. They are one of the most serious consequences of osteoporosis; 
and often caused by low-energy trauma. All patients with this type of fracture often 
need prolonged hospitalization, with almost all requiring surgical intervention.(1) It is 
estimated that, after a year of hip fracture 20 to 30% of these patients die,(2) 50-60% 
have some kind of functional and/or motor loss and only 30-40% of patients obtain 
functional recovery levels prior to fracture. The majority still requires long-term 
assistance care, so their medical and socio-economic impact is meaningful and is not 
limited to the event itself, but rather its consequences.(1)  
In Portugal, between year 2000 and 2008, 77 083 hip fractures were recorded(1) and 
studies obtained mortality values of 31% in men and 14.1% in women, after 6 months 
of hip fracture. In the same study, the overall mortality at 12 months was 26.8%, with 
values of 48.3% in men and 22.2% in women. In general, mortality rates for this cause 
increases with age and is more frequent in males, where complications also tend to be 
more serious.(2) All-cause mortality risk in the first 3 months subsequent to hip fracture 
in older adults increases by 5 to 8-fold. Both women and men face increased annual 
mortality over time. Excess annual mortality after hip fracture is higher in men than in 
women at any given age.(3)  
Copeland et al.(4) developed and validated a score system named POSSUM 
(Physiological and Operative Severity Score for the enUmeration of Mortality and 
morbidity) featuring 18 factors divided into two component parts 12 physiological 
factors (PS) and 6 operative factors (OS). Each factor is scored exponentially increasing 
from 1 to 8 (1, 2, 4 and 8) dependent upon grading. This system has also been 
subsequently used for comparing surgeons, resource usage and to compare surgical 
outcomes in different countries.(5) 
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A new risk model (P-POSSUM) was developed and validated in a large single centre 
cohort in Portsmouth using alternative risk equations for the same variables.(6) 
However, due to the original authors’ lack of confidence in the reporting of 
perioperative complications this model has no morbidity prediction equation.(6) The 
POSSUM and P-POSSUM systems have proved to be the most reliable and widely 
applicable scoring methods, with studies showing its effectiveness in predicting 
mortality and morbidity rates.(4, 6) Orthopedic-POSSUM (O-POSSUM) system, a minor 
adjustment of the POSSUM scoring system, demonstrates that POSSUM can be used as 
an audit aid to assess the quality of orthopaedic care.(7, 8)  
The aim of this study is to evaluate the performance POSSUM system score (POSSUM, 
P-POSSUM and O-POSSUM) on predicting 30-day morbimortality of elderly patients 
undergoing emergent hip fracture surgery. 
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Methods 
Ethics 
This study has received ethical approval from São João Health Centre Medical Ethics 
Committee, Porto, Portugal on 8th November 2016.  
Study design 
A retrospective cohort study was conducted in all elderly patients (65 or more years-
old) admitted, at a University Hospital (São João’s Hospital), with hip fracture, that 
underwent surgery, from 1st January 2014 to 31st December 2015.   
Patients 
From 408 patients submitted to hip fracture surgery, 328 were excluded for not being 
submitted to emergency surgery. Data from the remaining 80 was retrospectively 
collected from the clinical files and included patient age and gender, diagnosis, type of 
surgery, date of admission, surgery and discharge of the hospital, ASA, comorbidities, 
physiological and operative parameters, morbidity and mortality.  
POSSUM system 
The POSSUM score describes 18 factors in two component parts: 12 physiological 
factors (PS) and 6 operative factors (OS) (Table 1). Each factor is scored exponentially 
increasing from 1 to 8 (1, 2, 4 and 8) dependent upon grading.(4, 6, 7) From these values 
predicted mortality can be calculated using formulae described. P-POSSUM, using 
alternative risk equations for the same variables, also calculate the predicted 
mortality.(6) Almost all the score variables were available for every patient, but when a 
figure was missing, a score of 1 was allocated. 
PS and OS were calculated for each admitted patient and entered onto a database and 
from these values POSSUM, P-POSSUM and O-POSSUM scores were calculated for 
each patient. Predictions of mortality and morbidity for individual patients were 
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estimated using the following equations,(4, 6, 7) in which R1 relates to the mortality risk 
and R2 to the morbidity risk: 
Mortality:  
POSSUM Ln[R1/(1-R1)]= -7.04 + (0.13 x PS) + (0.16 x OS) 
P−POSSUM Ln[R1/(1-R1)]= -9.065 + (0.1692 x PS) + (0.155 x OS) 
O-POSSUM Ln [R1/(1-R1)] = -7.04 + (0.13 x PS) + (0.16 x OS) 
Morbidity: 
O-POSSUM Ln [R2/(1-R2)] = -5.91 + (0.16 x PS) + (0.19 x OS) 
These are logistic regression models calculated from PS and OS scores. PS and OS 
scores are calculated as the sum of the score of each of the items.  
The outcome was assessed as 30-day morbidity and mortality, which allowed 
comparability with the system for general surgery. The hospital mortality and long-
term mortality (at 30, 60 and 90 days) was accessed through the consultation of the 
Electronic Health Record – SClinic and RNU – Registo Nacional de Utentes (National 
Registers of Patients). The presence of the following complications was recorded as 
morbidity: infection, hemorrhage, other wound problems, thromboembolic 
complications, cardiac, respiratory, renal and unanticipated displacement of an 
implant. Exact definitions have been describe previously.(4) We also recorded other 
complications as non-fatal cardiac arrest, angina and other cardiac complications, 
pleural effusion, pneumothorax, bronchospasm, newly required respiratory support, 
newly required supplemental oxygen and other pulmonary complications, defined by 
ESA-ESICM joint taskforce on perioperative outcome measures.(9)  
Statistical analysis 
Descriptive statistics are presented as numbers and percentages for categorical 
variables; and as mean and standard deviation (SD) for continuous variables, or as 
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median and inter-quartile range (IQR – 25th percentile – 75th percentile), if the 
variable empirical distribution function was skewed. 
The quality of the POSSUM system score models for mortality and morbidity was 
assessed. Models goodness-of-fit was assessed by the Hosmer-Lemeshow statistic and 
test and standardized mortality/morbidity ratios. Discriminative/predictive power of 
the models was evaluated by ROC curve analysis. 
A predictive model like a simple diagnostic test for a particular disease or outcome 
may classify patients into two groups: those with the outcome as assessed by the test 
result (test positive) and those without it (test negative). A model or a test are 
assessed by its ability to diagnose the outcome correctly, whether this is positive or 
negative.(10) The Receiver Operating Characteristic (ROC) curve is a plot of sensitivity vs 
1 - specificity and it's one of the most common measures of the global test or model 
discrimination ability. This curve assesses how well a test or a model discriminates 
individuals into two classes, such as death and alive comparing the test against the 
actual outcome. The area under the curve (AUC) of the plot (also known as the C-
statistic or C-index) assess the discrimination, with 1 being a perfect discriminating test 
and 0.5 having no discriminative value.(10-12) Discrimination is acceptable for 0.7 ≤ AUC 
<0.8, excellent for 0.8 ≤ AUC < 0.9 and outstanding for AUC ≥0.9.(12) Analysis via ROC 
curves therefore provides not only a useful means to assess the diagnostic accuracy of 
a given test or predictive model, but also allows for different diagnostic tests or 
predictive models to be compared.(10) 
To evaluate model performance it is also important to know whether or not the 
number of observed events matches the number of predicted events over the range of 
model predictions. An assessment of calibration or goodness-of-fit of a predictive 
model may, for example, directly compare the observed and predicted probabilities of 
the event across subgroups. Because “observed risk” or proportions can only be 
estimated within groups of individuals, measures of calibration usually form subgroups 
and compare predicted probabilities and observed proportions within these 
subgroups.(11) The Hosmer-Lemeshow test (H-L T) is the most popular measure of 
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goodness-of-fit which forms such subgroups, typically using deciles of estimated risk of 
events. Within each decile of risk, the estimated observed proportion and the average 
estimated predicted probability are calculated and compared.(11) The estimated 
mortality and morbidity rates for each individual and group are obtained through the 
predictions calculated with each one of the model equations (POSSUM, P-POSSUM or 
O-POSSUM). The H-L T statistic has a chi-squared distribution with g-2 degrees of 
freedom, where g is the number of subgroups formed. Although deciles of event risk 
are most commonly used to form subgroups, other categories, such as those formed 
on the basis of the predicted probabilities themselves (such as 0 to <5%, 5 to <10%, 
etc.), may in some cases be more clinically useful.(11) 
Standardized Mortality Ratio (SMR) is a ratio between the observed number of deaths 
in a study population and the expected number of deaths, based on the age- and sex-
specific rates in a standard population and the age and sex distribution of the study 
population. If the SMR is significantly greater than 1.0, there is evidence of "excess 
deaths" in the study population. 
The statistical significance level was set at 5% and differences were considered 
statistical significant when P<0.05. Statistical analyses were carried out using SPSS 
23.(13) 
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Results  
Over a period of 24 months (from 1st January 2014 to 31st December 2015) there 
were 408 orthopedic hip operations of which 80 (19.6%) were emergency procedures 
(36 in 2015 and 44 in 2014). Of these surgeries, 24 (30%) were total hip replacements 
and 56 (70%) were partial hip replacements. The mean age of individuals studied was 
84.1 ± 8.6 SD, with 81% being female. Other baseline demographic and clinical 
characteristics of the sample are described in Table 2.  
The overall rate of 90 days mortality was 13.8% (of which 54.5% occurred during the 
hospitalization). The overall rate of 30 and 60 days mortality were respectively 6.3% 
and 7.5%. The overall rate of 30 days morbidity was 38.8%. The detailed list of 
postoperative complications used to classify the morbidity status is described in Table 
3.  
The POSSUM system logistic regression equation yields an overall predicted 30 days 
mortality of 9.41 patients (versus 5 observed) for O-POSSUM/POSSUM and 3.76 
patients (versus 5 observed) for P-POSSUM. The O-POSSUM equation predicted 30 
days morbidity of 39.16 patients (versus 31 observed) (Tables 4 to 6).  
Analysis of area under the Receiver Operating Characteristic (ROC-AUC) curves of 
POSSUM system showed good discriminative ability for mortality (AUC=0.879; 95%CI 
0.763-0.994) but poor for morbidity (AUC=0.647; 95%CI 0.524-0.771) (Figure 1 to 2).  
All models showed good calibration as assessed by the ROC curve analysis and 
adequate goodness of fit as assessed by the Hosmer-Lemeshow test (H-L T) (H-L T p-
values for O-POSSUM/POSSUM and P-POSSUM were respectively 0.4627 and 0.2476 
for mortality and 0.0932 for O-POSSUM morbidity) (Tables 4 to 6). 
Standardized Mortality Ratio (SMR) indicated significantly fewer than expected deaths 
for O-POSSUM/POSSUM (0.525; 95%CI 0.065-0.985) but not for P-POSSUM (1.321; 
95%CI 0.163-2.479). Standardized Morbidity Ratio (SMbR) demonstrated that observed 
and expected morbidity was similar (0.778; 95%CI 0.504-1.052). 
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Discussion  
While some studies have found evidence that POSSUM adequately predicts individual 
patient morbidity and mortality risk,(14-16) others have found this score significantly 
overestimates mortality.(17-19) 
P-POSSUM has proven to more accurately predict in-hospital mortality than 
POSSUM.(6, 14, 18-20) Studies performed in different settings have shown P-POSSUM to 
both over-predict(17, 21) and under-predict mortality.(14, 22, 23)  
A study with patients undergoing major digestive surgery showed poor calibration 
(goodness of fit) and overestimation of O:E ratios, which considerably limits the value 
of P-POSSUM for outcomes prediction for particular patients.(24) In others studies, P-
POSSUM had the least overestimation making it the most useful predictor of likely 
postoperative mortality.(25, 26) POSSUM, particularly in lower-risk groups, generally 
overpredicts mortality(14, 26) and morbidity.(25)  
The performance of these models for a variety of surgical specialties, with a systematic 
review(27) has also been explored, with the P-POSSUM being reported as the most 
accurate model for predicting postoperative mortality after colorectal cancer surgery 
and the original POSSUM model as accurate in predicting post-operative 
complications. However, discrepancy between observed to expected mortality 
amongst individual studies is large. Similar O:E discrepancies have been reported in 
other surgical specialties.(26, 28) 
This study shows that POSSUM system score models (POSSUM, P-POSSUM and O-
POSSUM) have excellent discriminative ability between survivors and non-survivors, 
which corroborates previous studies,(7, 8) but we couldn't demonstrate the same for 
morbidity. Regarding model calibration, all models showed good calibration and 
goodness of fit as assessed by the Hosmer-Lemeshow test (H-L T). Concerning 
Standardized Mortality Ratios (SMR), only the O-POSSUM/POSSUM indicated 
significantly fewer than expected deaths.  
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However, the results and conclusions of the present study ought to be seen in the 
context of its limitations. First, the retrospective design of our study imposed some 
limitations, such as missing or incomplete information that is required to calculate 
some variables. Second, since this study was conducted in a single hospital and only 
included elderly patients undergoing emergent hip fracture surgery, the sample size is 
reduced and the number of events is limited. Expanding this study to other centers or 
performs future prospective studies would improve the findings. 
In conclusion, and despite the limitations of the study, we demonstrated that POSSUM 
system is better for predicting mortality than morbidity; and the POSSUM system can 
be safely used to predict 30-day mortality in elderly patients undergoing emergent hip 
fracture surgery, having excellent discriminative ability and good calibration. 
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Tables and Figures 
 
Table 1. POSSUM system physiology and operative score variables 
Physiology score Operative score 
Age Grade of operation 
Cardiac Signs Number of procedures 
Respiratory Signs Total blood loss 
Systolic blood pressure Peritoneal soiling 
Pulse rate Presence of malignancy 
Glasgow Coma Score Timing of operation 
Hemoglobin level  
White blood cell count  
Serum sodium  
Serum potassium  
Serum urea  
Eletrocardiogram  
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Table 2. Patient demographics, ASA, Charlson and POSSUM baseline data. 
Number of patients n=80 
Median age (years) (IQR) 85 (78.25 – 90.75) 
Women (%) 65 (81.3) 
Men (%) 15 (18.8) 
Median ASA (IQR) 3 (2 – 3) 
Mean Charlson score (±SD) 2.1 (1.8) 
Mean Charlson score age adjusted (±SD) 5.1 (3.3) 
Mean hemoglobina (±SD) 12.4 (1.7) 
Mean white blood cell count (±SD) 10.7 (3.5) 
Mean serum sodium (±SD) 136.6 (4.3) 
Mean serum potassium (±SD) 4.1 (0.5) 
Mean serum urea (±SD) 56 (28.2) 
Abnormal ECG (%) 23.8 
Known cardiac co-morbidity (%) 81.3 
Known respiratory co-morbidity (%) 3.8 
Mean days of post-operative hospitalization (±SD) 12.1 (16.4) 
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Table 3. The number of patients with postoperative 
complications.  
Complication n (%) 
Cardiovascular   
  Non-fatal cardiac arrest 0 (0) 
  Acute myocardial infarction 4 (5) 
  Congestive heart failure 1 (1.3) 
  New cardiac arrhythmia 0 (0) 
  Angina 0 (0) 
  Stroke 0 (0) 
  Other cardiac complications   2 (2.5) 
Pulmonary   
  Pulmonary embolism 1 (1.3) 
  Respiratory infection 8 (10) 
  Respiratory failure 9 (11.3) 
  Pleural effusion 4 (5) 
  Atelectasis 2 (2.5) 
  Pneumothorax 1 (1.3) 
  Bronchospasm 0 (0) 
  Aspiration pneumonitis 1 (1.3) 
  New requirement for respiratory support 1 (1.3) 
  New requirement for supplemental oxygen 6 (7.5) 
  Other pulmonary complications 0 (0) 
Renal  11 (13.8) 
Postoperative hemorrhage 8 (10) 
Infection  
  Surgical site infection (superficial) 4 (5) 
  Surgical site infection (deep) 2 (2.5) 
  Surgical site infection (organ/space) 0 (0) 
  Urinary  8 (10) 
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  Infection source uncertain 2 (2.5) 
Other wound problems 2 (2.5) 
Unanticipated displacement of an implant 6 (7.5) 
Some patients had multiple complications. 
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Table 4. Hosmer-Lemeshow goodness of fit test for O-POSSUM/POSSUM for 30 days mortality 
Groups 
of risk 
(deciles) 
Number of 
observed 
deaths  
Number of 
expected 
deaths  
Mean risk of 
observed 
mortality 
Mean risk of 
expected 
mortality 
O:E 
HL 
Statisti
c 
1 2 1.420 0.500 0.355 1.410 0.370 
2 1 2.570 0.083 0.214 0.390 1.220 
3 0 0.450 0.000 0.149 0.000 0.530 
4 2 1.250 0.200 0.125 1.601 0.520 
5 0 1.460 0.000 0.098 0.000 1.620 
7 0 0.590 0.000 0.084 0.000 0.640 
8 0 0.600 0.000 0.074 0.000 0.640 
9 0 0.530 0.000 0.066 0.000 0.570 
10 0 0.550 0.000 0.055 0.000 0.580 
chi-square = 6.68; df = 7; p-value = 0.4627     
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Table 5. Hosmer-Lemeshow goodness of fit test for P-POSSUM for 30 days mortality 
Groups 
of risk  
Number of 
observed 
deaths 
Number of 
expected 
deaths 
Mean risk of 
observed 
mortality 
Mean risk of 
expected 
mortality 
O:E 
HL 
Statisti
c 
1 2 0.850 0.500 0.212 2.356 1.980 
2 1 1.190 0.083 0.099 0.840 0.030 
3 0 0.170 0.000 0.057 0.000 0.180 
4 2 0.440 0.200 0.044 4.523 5.740 
5 0 0.470 0.000 0.031 0.000 0.480 
7 0 0.180 0.000 0.025 0.000 0.180 
8 0 0.170 0.000 0.021 0.000 0.180 
9 0 0.150 0.000 0.018 0.000 0.150 
10 0 0.140 0.000 0.014 0.000 0.140 
chi-square = 9.07; df = 7; p-value = 0.2476     
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Table 6. Hosmer-Lemeshow goodness of fit test for O-POSSUM for 30 days morbidity 
Groups 
of risk  
Number of 
observed  
Number of 
expected  
Mean risk of 
observed morbidity 
Mean risk of 
expected morbidity 
O:E 
HL 
Statistic 
1 3 3.490 0.750 0.872 0.861 0.530 
2 6 8.780 0.500 0.732 0.683 3.290 
3 0 1.890 0.000 0.629 0.000 5.100 
4 6 5.680 0.600 0.568 1.056 0.040 
5 6 7.250 0.400 0.483 0.828 0.420 
7 2 3.030 0.286 0.433 0.660 0.620 
8 4 3.150 0.500 0.394 1.269 0.380 
9 1 2.850 0.125 0.357 0.351 1.870 
10 3 3.040 0.300 0.304 0.987 0.000 
chi-square = 12.23; df = 7; p-value = 0.0932    
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Figure 1   
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Figure 2  
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Captions  
Figure 1. Receiver operating characteristic curve for performance of POSSUM system 
of 30 days mortality.  
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Figure 2. Receiver operating characteristic curve for performance of O-POSSUM score 
of 30 days morbidity.  
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grant permission for the publication of photographs or other material that might identify
them. If the consent form for your research did not specifically include this, please obtain it
or remove the identifying material.
A statement to the effect that such consent had been obtained must be included in the
‘Methods’ section of your paper. If necessary the Editors may request a copy of any
consent forms.
Ethics committee approval 
All articles dealing with original human or animal data must include a statement on ethics
approval at the beginning of the Methods section. This paragraph must contain the
following information: the name and address of the ethics committee responsible; the
protocol number that was attributed by this ethics committee; the name of the Chairperson
of the ethics committee (or the person who approved the protocol) and the date of
approval by the ethics committee. 
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Ethical approval for this study (Ethical Committee N° NAC 207) was provided by the Ethical
Committee NAC of Geneva University Hospitals, Geneva, Switzerland (Chairperson Prof N.
Dupont) on 12 February 2015.
In addition and as stated above, for studies or case reports conducted on human
participants you must state clearly in the text that you obtained written informed consent
from the study participants; please also look at the latest version of the Declaration of
Helsinki. Similarly, for experiments involving animals you must state the care of animal and
licensing guidelines under which the study was performed and report these in accordance
with the ARRIVE (Animals in Research: Reporting In Vivo Experiments) statement. If ethics
clearance was not necessary, or if there was any deviation from these standard ethical
requests, please state why it was not required. Please note that the editors may ask you
to provide evidence of ethical approval. If you have approval from a National Drug Agency
(or similar) please state this and provide details, this can be particularly useful when
discussing the use of unlicensed drugs.
Trial registration The Journal requires authors to prospectively register the protocol of any
interventional trial (interventional studies include randomised and nonrandomised trials on
humans), which started enrolment of patients after 1 January 2015. This is a mandatory
requirement for subsequent publication in the Journal. Authors of interventional trials who
have started enrolment of patients before 1 January 2015, and who have not prospectively
registered their protocol, may submit manuscripts to the Journal who will consider them for
possible publication on the basis of their individual methodological quality. The date of start
of enrolment of patients must be stated in the Results section. For more information, see
the EJA Editorial: Elia and Wager. Why should clinical trials be registered? Eur J Anaesthesiol
2014; 31:397-400.
Acceptable registries are:
www.anzctr.org.au 
www.clinicaltrials.gov
www.ISRCTN.org 
www.umin.ac.jp/ctr/index/htm 
www.trialregister.nl 
https://eudract.ema.europa.eu/
and those listed at: http://www.who.int/ictrp/network/primary/en/index.html
Adherence to international guidelines on adequate data reporting 
The European Journal of Anaesthesiology adheres to the guidelines on adequate data
reporting that were established by The Enhancing the QUAlity and Transparency Of health
Research (EQUATOR) network (http://www.equator-network.org/home/). For more
information, see the EJA Editorial: Guidelines on adequate data reporting: use them!
Authorship 
We ask all authors to confirm that they have read and approved the paper. Second, we ask
all authors to confirm that they have met the criteria for authorship as established by the
ICMJE, believe that the paper represents honest work, and are able to verify the validity of
the results reported.
All persons designated as authors should qualify for authorship and all those who qualify
should be listed. Each author should have participated sufficiently in the work to take public
responsibility for appropriate portions of the content. One or more authors should take
responsibility for the integrity of the work as a whole, from inception to published article.
Authorship credit should be based only on 1) substantial contributions to conception and
design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article
or revising it critically for important intellectual content; 3) final approval of the version to be
published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of
data or general supervision of the research group, by themselves, do not justify
authorship. All others who contributed to the work who are not authors should be named
in the Acknowledgements section.
Retractions 
The EJA is a member of the Committee on Publication Ethics (COPE), and also refers to the
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Compliance with Research Funding Agency Accessibility Requirements 
A number of research funding agencies now require or request authors to submit the “post-
print” (the final manuscript, in Word format, after peer-review and acceptance for
publication but prior to the publisher’s copyediting, design, formatting, and other services)
to a repository that is accessible online by all without charge. As a service to our authors,
LWW will identify to the National Library of Medicine (NLM) articles that require deposit and
will transmit the post-print of an article based on research funded in whole or in part by the
National Institutes of Health, Wellcome Trust, or the Howard Hughes Medical Institute to
PubMed Central. Authors of research funded by other funding agencies may submit the
post-print 12 months after publication of the final article, or 6 months after publication if the
funding agency mandates a shorter time-frame.
Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual
unrestricted online access to their published article to readers globally, immediately upon
publication. Authors may take advantage of the open access option at the point of
acceptance to ensure that this choice has no influence on the peer review and acceptance
process. These articles are subject to the journal's standard peer-review process and will
be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be
paid within 30 days by the author, funding agency or institution. Payment must be
processed for the article to be published open access. For a list of journals and pricing
please visit our Wolters Kluwer Open Health Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant
Wolters Kluwer an exclusive license to publish the article and the article is made available
under the terms of a Creative Commons user license. Please visit our Open Access
Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of
publication under the terms of the Creative Commons License Attribution-NonCommerical
No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial
purposes nor does it cover the reuse or modification of individual elements of the work
(such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative
Commons Attribution (CC BY) license is able to meet that requirement through the available
open access license for approved funders. Information about the approved funders can be
found here: http://www.wkopenhealth.com/inst-fund.php
FAQ for open access
http://www.wkopenhealth.com/openaccessfaq.php
Copyright assignment 
Each author will be required to complete the journal's copyright transfer agreement (CTA),
which includes a section on the disclosure of potential conflicts of interest based on the
recommendations of the ICMJE. Authors will receive an email notification with a link to our
submission system where the CTA and disclosure questions can be completed
electronically. The request is usually sent to authors once a revised submission is received,
but may also be requested at the original submission stage. The manuscript cannot be
published until all authors have completed these requirements.
A copy of the form is made available to the submitting author within the Editorial
Manager submission process. Co-authors will automatically receive an Email with
instructions on completing the form upon submission.
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Submissions 
All manuscripts and materials must be submitted through the web-based tracking system at
https://www.editorialmanager.com/eja/. Submissions should be in English, UK spelling is
preferred. The site contains instructions and advice on how to use the system. Authors
should NOT in addition then post a hard copy submission to the editorial office, unless you
are supplying artwork, letters or files that cannot be submitted electronically, or have been
instructed to do so by the editorial office. 1.5 spacing should be used throughout the
manuscript, which should include the following sections, each starting on a separate page:
Title Page, Abstract, Text, Acknowledgements, References, Tables and Figures, and
captions. Margins should be not less than 3 cm. Pages should be numbered consecutively,
beginning with the Title Page, and the page number should be placed in the top right hand
corner of each page. Two letter abbreviations should be avoided. Longer abbreviations
should be defined on their first appearance in the text; those not accepted by international
bodies should be avoided.
Article Types
Randomised Controlled Trials 
Authors are requested to report these in accordance with the CONSORT (Consolidated
Standards of Reporting Trials) statement [www.consort-statement.org]. This ensures that
enough information is provided for editors, peer reviewers, and readers to see how the
study was performed and to judge whether the findings are likely to be reliable (see EJA
Editorial: Adherence to guidelines for improved quality of data reporting: where are we
today?). Please provide the following:
A flow chart showing the progress of participants through the study. The example
flowchart may be adapted as required.
A checklist for editors and reviewers (not for publication) showing that you have
described the recommended respective key points in your report.
The trial registration number and name of the registry. This must be stated at the end of
the abstract (see the relevant example in the section 'Structured Abstract').
Maximum length of reports of randomised controlled trials is 3500 words. Please provide a
structured abstract (300 words, see subheading Structured Abstract).
Observational Studies (Cohort, Case-control, Cross-sectional, Case Series) 
Authors are requested to report these in accordance with the STROBE (STrengthening the
Reporting of OBservational studies in Epidemiology) statement [www.strobe-
statement.org].
Maximum length of reports of observational studies is 3500 words. Please provide a
structured abstract (300 words, see subheading Structured Abstract).
Studies of Diagnostic Accuracy 
Authors are requested to report these in accordance with STARD (STandard for the
Reporting of Diagnostic accuracy) statement [www.stard-statement.org].
Maximum length of reports of Diagnostic studies is 3500 words. Please provide a structured
abstract (300 words, see subheading Structured Abstract).
Systematic Reviews (with or without meta-analysis) 
Authors are requested to submit these as ‘Original articles’ (not ‘Reviews’) and report them
in accordance with the PRISMA (Transparent Reporting of Systematic Reviews and Meta-
Analyses) Statement [www.prisma-statement.org]. This ensures that enough information is
provided for editors, peer reviewers, and readers to see how the study was performed and
to judge whether the findings are likely to be reliable (see EJA Editorial: Adherence to
guidelines for improved quality of data reporting: where are we today?). Please provide the
following:
• A flow chart showing the progress of retrieved reports through the review 
• A checklist for editors and reviewers (not for publication) showing that you have
described the recommended respective key points in your report.
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Maximum length of reports of systematic reviews is 3500 words. Please provide a
structured abstract (300 words, see subheading Structured Abstract). Authors are
encouraged to publish additional material (for instance, large tables, figures with forest
plots, data from subgroup analyses etc.) as Supplemental Digital Content (see above for
details).
Conventional, Non-systematic Reviews 
These are usually commissioned. Maximum length of reviews is 3500 words. Please provide
an unstructured abstract (max. 250 words). Please include a title page giving the author's
name, address, email address, phone and fax numbers, as well as an Acknowledgement
statement (see paragraph: Acknowledgements) and signed copyright forms.
Practice Guidelines 
In general, published statements intended to guide clinical care (e.g., Guidelines, Practice
Parameters, Recommendations, Consensus Statements, Position Papers) should describe:
1. The clinical problem to be addressed;
2. The mechanism by which the statement was generated;
3. A review of the evidence for the statement (if available), and;
4. The statement on practice itself.
As more than one group or society may issue statements on the same topic, this often
results in confusion amongst clinicians. To minimize confusion and to enhance transparency,
such statements should begin with the following bulleted phrases, followed by brief
comments addressing each phrase:
What other guideline statements are available on this topic?
Why was this guideline developed?
How does this statement differ from existing guidelines?
Why does this statement differ from existing guidelines?
Editorials 
Editorials discuss issues that are not directly related to published material. Editorials are
usually commissioned. Editorials should be up to 1500 words long with no more than 15
references. Please include a title page giving all authors' names, addresses, email
addresses, phone and fax numbers, as well as an Acknowledgement statement (see
paragraph: Acknowledgements) and signed copyright forms. Editorials do not have an
abstract.
Invited Commentaries 
Commentaries discuss issues that are directly related to published material. Commentaries
accompany original articles, critically appraise their results and put their conclusions into a
wider context. Commentaries are always commissioned and should be up to 1000 words
long with no more than 10 references. Commentaries do not have an abstract. Please
include a title page giving the author's name, address, email address, phone and fax
numbers, as well as an Acknowledgement statement (see paragraph: Acknowledgements)
and signed copyright forms.
Correspondence 
In this section, we publish short reports (that may be shortened versions of original
research) case reports, letters that refer to published material and replies. Items in the
Correspondence section are peer reviewed. Please look at a very recent copy of the
European Journal of Anaesthesiology to see how the material should be presented. The
format (layout) for the Correspondence section is quite different from our other articles. The
absolute maximum is 1000 words, which must include the space for any tables and
illustrations (this is approximately two sides of printed matter in the Journal). There should
be no more than 4 authors, if more than 4 are stated then a letter justifying the number of
authors and listing what each contributed should be submitted with the article. References
are limited to seven.
Correspondence articles do not have an abstract. Please include a title page giving the
author's name, address, email address, phone and fax numbers, as well as an
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Acknowledgement statement (see paragraph: Acknowledgements) and signed copyright
forms.
Case Reports 
Case reports should follow the guidance for correspondence (see above). In addition case
reports dealing with patients must state in the text that informed consent to publication
was obtained from the patient or guardian (or was granted by a competent ethics
committee).
Presentation of papers
Title Page 
The Title Page should carry the full title of the paper and a short title to be used as a
‘running head’ (and which should be so identified). Please, include the study design in the
title; for instance, “randomised controlled trial”, or “systematic review”. Titles should be as
informative and complete as possible. The EJA Editorial: How to write a good title provides
some help. The first name, middle initial and last name of each author and their affiliations
should appear. Academic degrees should not be stated. If the work is to be attributed to a
department or institution, its full name should be included. The name and address of the
corresponding author and the name and address of the author to whom requests for
reprints should be made should also appear on the Title Page.
Structured Abstract 
For original articles, the second page should carry an abstract, which will be printed at the
beginning of the paper and should not be more than 300 words. Use the following
headings and information as appropriate (which are adapted from the BMJ and JAMA
websites). The abstract should be usable as it stands by abstracting journals. Because of
this it should contain some numerical data (if appropriate), not just statistical statements,
and it should not contain abbreviations or references (see EJA Editorial: Writing the
abstract: completeness and accuracy matter).
Example: Randomised controlled trials, observational studies diagnostic studies, animal
studies
Background: Explaining the clinical (or other) importance of the study question.
Objective(s): Including a clear statement of the main aim(s) of the study and the major
hypothesis tested or research question posed. Avoid statements such as “We aimed to
evaluate the effectiveness of X”.
Design: For example, randomised controlled study, case control study, crossover study,
observational study, survey, diagnostic test etc.
Setting: Include the level of care e.g. primary, secondary; number of participating centres.
Be general rather than give the name of the specific centre, but give the geographical
location if this is important. Include the dates of the study period.
Patients, other participants (for instance, volunteers) (delete what does not apply): Numbers
entering and completing the study, sex, and ethnic group of patients if appropriate. Give
clear definitions of how selected, entry and exclusion criteria. For animal studies, this
information should be included in the Design or Setting section.
Intervention(s): What, how, when and for how long. This heading can be deleted if there
were no interventions but should normally be included for randomised controlled trials,
cross over trials, and before and after studies.
Main outcome measures: What was the primary endpoint? What outcome measures were
planned in protocol, which were finally measured (if different, explain why)?
Results: Main results with (for quantitative studies) 95% confidence intervals and, where
appropriate, the exact level of statistical significance.
Conclusions: Primary conclusions and their implications, suggest areas for further research if
appropriate.
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Trial registration: The trial registration number and the name of the registry must be
stated at the end of the abstract, for example: “Trial registration: Clinicaltrials.gov
identifier: NCT00405977.”
Example: Systematic reviews with or without meta-analyses
Background: Explaining the clinical (or other) importance of the study question.
Objective(s): Including a clear statement of the main aim(s) of the study and the major
hypothesis tested or research question posed. Avoid statements such as "We aimed to
evaluate the effectiveness of X".
Design: For example: Systematic review of randomised controlled trials with meta-analyses.
Data sources: Where included studies were retrieved from (databases)? Include years
searched.
Eligibility criteria: Describe inclusion and non-inclusion criteria of selected studies.
Results: Main results with (for quantitative studies) 95% confidence intervals and, where
appropriate, the exact level of statistical significance.
Conclusions: Primary conclusions and their implications, suggest areas for further research if
appropriate.
Text 
The remainder of the text should be divided into sections headed Introduction, Methods
(including ethical and statistical information), Results, and Discussion (including a
conclusion). Subheadings, for instance, in the Methods, Results or Discussion section are
allowed.
Acknowledgements 
The acknowledgements section should be headed 'Acknowledgements relating to this
article' and contain the following distinct statements in separate paragraphs:
1. Assistance with the article. Acknowledgements should be made only to those who have
made a substantial contribution to the study. Authors are responsible for obtaining written
permission from people acknowledged by name in case readers infer their endorsement of
data and conclusions. If there was no assistance state: none.
2. Financial support and sponsorship. You must make reference to all relevant sources of
funding concerning this article. If there were no sources of funding please state: none.
3. Conflicts of interest. You must make reference to all relevant conflicts of interest
concerning this article including financial, consultant, institutional and other relationships
that might lead to bias or a conflict of interest. If there are no conflicts of interest please
state: none.
4. Presentation (for original articles only). Presentations of preliminary data at, for example,
international meetings should be acknowledged separately. If preliminary data was not
previously presented please state: none.
For example: 
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should be numbered in accordance with the sequence established by the first identification
in the text of the particular table or illustration.
Use the Vancouver reference system as adopted by the U.S. National Library of Medicine
ensuring that all journal titles conform to Index Medicus approved abbreviations. If in
doubt, look up the reference list of a recent paper published in the European Journal of
Anaesthesiology.
Avoid citing abstracts unless from a MEDLINE or EMBASE indexed journal. Unpublished
observations and personal communications should not be used as references, although
references to written (not verbal) communications may be inserted (in parentheses) in the
text. Manuscripts that have been accepted but not yet published (e.g. Epub ahead of print)
should be included in the list, followed by (in press). Information from manuscripts not yet
accepted may be cited only in the text as (unpublished observations). Authors should verify
references against the original documents before submitting the article.
Electronic or online references should be cited in the reference list only if the material
referenced is a specific article (e.g. a paper published in a web-based journal); see below
for correct style. Less specific references (e.g. the web pages of societies, organisations
and university departments) should not appear in the references; instead the URL should
be cited in full in the text.
Authors must confirm that the details of these references are accurate and complete. In the
full list of references give the names and initials of all authors. If there are more than six,
cite only the first three names followed by et al. The authors' names are followed by the
title of the article: the title of the journal (italics) abbreviated according to the style of Index
Medicus: the year of publication: the volume number (in bold): the first and last page
numbers in full followed by a full stop. Titles of books should be followed by the town and
country of publication, the publisher, the year and inclusive page numbers. See the
following examples:
Journal articles 
Pollard BJ, Bryan A, Bennett D et al. Recovery after oral surgery with halothane, enflurane,
isoflurane or propofol anaesthesia. Br J Anaesth 1994; 72:559–566.
Books 
Korttila K. Recovery period and discharge. In: White P, ed. Outpatient Anaesthesia. New
York, USA: Churchill Livingstone Inc, 1990: 369–395.
Chapter in a book: 
Pessayre D, Feldmann G, Haouzi D, Fau D, Moreau A, Neumann M. Hepatocyte apoptosis
triggered by natural substances (cytokines, other endogenous molecules and foreign
toxins). In Cameron RG, Feuer G (editors): Apoptosis and its Modulation by Drugs. Handbook
of Experimental Pharmacology. Berlin: Springer-Verlag; 2000, pp. 59-108.
Electronic articles: 
Margolis PA, Stevens R, Bordley WC, Stuart J. From concept to application: the impact of a
community-wide intervention to improve the delivery of preventive services to children.
Pediatrics [online serial] 2001; 108:e42. 
http://www.pediatrics.org/cgi/content/full/108/3/e42. [Accessed 20 September 2001].
Tables 
References to tables should be made in order of appearance in the text and should be in
Arabic numerals in parentheses, e.g. (Table 1). Each table should be typed on a separate
sheet in 1.5 spacing. Tables should not be submitted as photographs. Each table should
have a brief title as a heading. Vertical rules should not be used. Place explanatory matter
in footnotes, not in the heading. Authors are discouraged from using abbreviations in
tables. If abbreviations are necessary then please explain them in the table’s footnotes.
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Statistics: Median should be given with interquartile range, e.g. median (IQR). Mean should
be given as mean ±SD and not SEM.
Be sure that each table is cited in the text. If you use data from another published or
unpublished source, obtain permission and acknowledge the source fully.
Authors are encouraged to submit non-essential tables as supplemental digital content for
publication online only. See Supplemental Digital Content section for more details.
Figures
A) Creating Digital Artwork 
1. Learn about the publication requirements for Digital Artwork:
http://links.lww.com/ES/A42 
2. Create, Scan and Save your artwork and compare your final figure to the Digital Artwork
Guideline Checklist (below). 
3. Upload each figure to Editorial Manager in conjunction with your manuscript text and
tables.
B) Digital Artwork Guideline Checklist 
Here are the basics to have in place before submitting your digital artwork:
Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution
PDF files are also acceptable.
Crop out any white or black space surrounding the image.
Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution
of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS)
file.
Photographs, radiographs and other halftone images must be saved at a resolution of
at least 300 dpi.
Photographs and radiographs with text must be saved as postscript or at a resolution of
at least 600 dpi.
Each figure must be saved and submitted as a separate file. Figures should not be
embedded in the manuscript text file.
Remember:
References to figures should be made in order of appearance in the text and should be
in Arabic numerals in parentheses, e.g. (Fig. 2).
Number figures in the figure legend in the order in which they are discussed.
Upload figures consecutively to the Editorial Manager web site and enter figure numbers
consecutively in the Description field when uploading the files.
If hard copies are submitted they should have a label pasted to the back bearing the
figure number, the title of the paper, the author’s name and a mark indicating the top of
the figure. Figures should be presented to a width of 82 mm or, when the illustration
demands it, to a width of 166 mm.
Photomicrographs must have internal scale markers. If photographs of people are used,
their identities must be obscured or their written consent to use the photograph must
have been obtained. If necessary the Editors may request copies of any consent forms.
If a figure has been published before, the original source must be acknowledged and
written permission from the copyright holder for both print and electronic formats should
be submitted with the material. Permission is required regardless of authorship or
publisher, except for documents in the public domain.
Figures may be reduced, cropped or deleted at the discretion of the editor.
Figure legends 
Captions should be typed in 1.5 spacing, beginning on a separate page. Each figure should
be assigned an Arabic numeral, e.g. (Figure 3) and a brief title as a heading. Internal scales
should be explained and staining methods for photomicrographs should be identified.
16/03/2017 Editorial Manager - European Journal of Anaesthesiology
http://edmgr.ovid.com/eja/accounts/ifauth.htm 10/11
Units of measurement 
Scientific measurements should be given in SI units. Blood pressure, however, may be
expressed in mmHg and haemoglobin as g dL-1.
Abbreviations and symbols 
Authors are discouraged from using abbreviations. If an abbreviation is necessary please
use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term
for which an abbreviation stands should precede its first use in the text unless it is a
standard unit of measurement.
Supplemental Digital Content 
Authors may submit supplemental digital content (SDC) to enhance their article’s text and
to be considered for online-only posting. SDC may include the following types of content:
text documents, graphs, tables, figures, graphics, illustrations, audio, and video. On the
Attach Files page of the submission process, please select Supplemental Audio, Video, or
Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our
production staff will create a URL with the SDC file. The URL will be placed in the call-out
within the article. SDC files are not copy-edited by LWW staff, they will be presented
digitally as submitted. For a list of all available file types and detailed instructions, please
visit http://links.lww.com/A142.
SDC Call-outs 
Supplemental Digital Content must be cited consecutively in the text of the submitted
manuscript. Citations should include the type of material submitted (Audio, Figure, Table,
etc.), be clearly labelled as "Supplemental Digital Content," include the sequential list
number, and provide a description of the supplemental content. All descriptive text should
be included in the call-out as it will not appear elsewhere in the article. 
For example: 
We performed many tests on the degrees of flexibility in the elbow (see Video,
Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results
inconclusive.
List of Supplemental Digital Content 
A listing of Supplemental Digital Content must be submitted at the end of the manuscript
file. Include the SDC number and file type of the Supplemental Digital Content. This text will
be removed by our production staff and not be published. 
For example: 
Supplemental Digital Content 1.wmv
SDC File Requirements 
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than
10 MBs, authors should first query the journal office for approval. For a list of all available
file types and detailed instructions, please visit http://links.lww.com/A142.
Reprints 
Reprints may be purchased using the appropriate form that will be made available with
proofs. Orders should be sent when the proofs are returned; orders received after this time
cannot be fulfilled.
English language editing 
If you are inexperienced in publishing medical articles in English then it may be helpful to
have your manuscript reviewed by a professional editor so that you submit it in
grammatically and syntactically acceptable English. The list below is provided for the benefit
of authors seeking assistance in writing and editing their manuscripts. The EJA does not
endorse any writing/editing services.
American Journal Experts (http://www.journalexperts.com/?rcode=LWW1 Discount
Available for LWW Journal Authors) 
BioMedES (Biomedical Editorial Services) (http://www.biomedes.co.uk) 
Biomedical Science Writers, LLC (http://www.biomedicalsciencewriters.com/index.htm) 
BoldFace Editors (http://www.boldfaceeditors.com) 
Cambridge Language Consultants (http://www.camlang.com/proof.cfm) 
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Council of Science Editors Manuscript Services Listing
(http://www.councilscienceeditors.org) 
Editage (http://www.editage.com) 
Elizabeth Betsch, ELS , Medical Edits.com (ejb@medicaledits.com) 
English Science Editing (http://www.english-science.com/journals.html) 
English Manager Science Editing (Australia) (http://www.sciencemanager.com/) 
ScienceDocs (http://www.sciencedocs.com) 
SciTechEdit International Science Editing (http://www.internationalscienceediting.com/) 
SquirrelScribe (http://www.squirrelscribe.com) 
Text Check (http://www.textcheck.com) 
The Medical Editor (http://www.themedicaleditor.com/) 
Write Science Right (http://writescienceright.com)
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Score POSSUM: 12 variáveis fisiológicas  e 6 scores operativos2 
• Comorbilidades: Índice de Charlson3 
    Índice de Charlson ajustado à idade3 
Análise Estatística: 
• Teste Hosmer Lemeshow (HL T)4 
• Razão Mortalidade/Morbilidade Padronizado (SMR)5 
• AUC-ROC 
 
Será o sistema Score POSSUM um bom preditor de mortalidade 
e morbilidade em doentes idosos submetidos a correção 
cirúrgica de fratura da anca? 
 
 Ana R. Teles*1,  José Castro2,,Inês Teixeira2, Joana Mourão1,2,Luis Azevedo2  
 
 
1 Serviço de Anestesiologia, Hospital São João, Porto, Portugal 
2 Faculdade de Medicina da Universidade do Porto 
O score POSSUM é um sistema validado para a previsão da 
morbilidade e mortalidade aos 30 dias de pós-operatório.1  
Objetivo: Avaliar o desempenho do sistema POSSUM 
(POSSUM, P-POSSUM and O-POSSUM) na previsão da 
morbimortalidade aos 30, 60 e 90 dias em doentes idosos 
submetidos a correção cirúrgica de fratura da anca. 
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  INTRODUÇÃO 
MÉTODOS 
Critérios de Inclusão: 
 
• Doentes idosos (≥ 65 anos)  
• Submetidos a correção de fratura 
da anca em contexto de urgência 
• Entre 1 de janeiro 2014 até 31 de 
dezembro de 2015 
Critérios de Exclusão: 
 
• Falta de informação 
• Cirurgia não urgente 
 
 
  RESULTADOS 
  DISCUSSÃO/ CONCLUSÃO 
Nº de doentes                                                       80 
Média idade (anos)(variação) 85 (78-91) 
Mulheres 65 (81.3%) 
Homens 15 (18.8%) 
ASA (mediana)(variação) 3 (2-3) 
Média Índice de Charlson (±DP) 2.1 (1.8) 
Média Índice de Charlson ajustado à idade(±DP) 5.1 (3.3)  
Média Hemoglobina (±DP) 12.4 (1.7)g/dL  
Média nº Leucócitos (±DP) 10.7 (3.5)x10^9/L  
Média Sódio sérico (±DP) 136.6 (4.3)mEq/L  
Média Potássio sérico (±DP) 4.1 (0.5)mEq/L  
Média Ureia sérica (±DP) 56 (28.2)mg/dL  
Anormalidades ECG 23.8% 
Tabela 1. Características dos doentes, Classificação ASA e Índice de Charlon 
Mortalidade Nº de doentes 
30 dias 5 (6.3%) 
60 dias 6 (7.5%) 
90 dias  11 (13.8%) 
Tabela 2. Mortalidade observada      Tabela 3. Morbilidade aos 30 dias. 
Morbilidade Observada Esperada 
Nº doentes 
31 
 (28.75%) 
39  
(48.75%) 
Figura 1. Desempenho do sistema POSSUM na previsão da mortalidade aos 30 
dias. 
Figura 2. Desempenho do sistema POSSUM na previsão da morbilidade aos 30 
dias. 
• Todos os modelos apresentaram, boa calibração e qualidade de 
ajuste.   
• O sistema POSSUM (POSSUM, P-POSSUM and O-POSSUM) 
mostrou excelente capacidade discriminativa relativamente à 
mortalidade. 
• Apenas O-POSSUM sobrevalorizou a mortalidade.  
• O modelo POSSUM não obteve um bom desempenho na previsão 
de morbilidade no nosso grupo de doentes (baixa calibração e 
discriminação). 
• O sistema POSSUM pode ser seguramente usado na previsão da 
mortaidade aos 30 dias em doentes submetidos a correção 
cirurgica de fractura da anca, em contexto de urgência. 
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